“…An existing example is the Brignola score which predicts relapse risk in asymptomatic Crohn's patients by measures erythrocyte sedimentation rate, white blood cell count, hemoglobin, albumin, alpha 2globulin, serum iron, Creactive protein, alpha 1glycoprotein, and alpha 2antitrypsin [41] . This has been hinted at in several IBD proteomic studies which differentiated UC and CD using protein profiles rather than discrete markers [22,24] . The role of multiple biomarkers is highlighted by OVA1, the first Food and Drug Administration approved proteomic panel of biomarkers, consisting of 5 markers as a multivariate index assay.…”